About Mankind Pharma
Mankind Pharma is a company based in Delhi (India) founded in 1991 by Greesh Juneja, Ramesh Chand Juneja, Ramesh Juneja, and Rajeev Juneja. Mankind Pharma has raised $367.2 million across 2 funding rounds from investors including ChrysCapital and Monet. The company has 21,320 employees as of March 31, 2024. Mankind Pharma has completed 2 acquisitions, including BSV Group and Upakarma. Mankind Pharma offers products and services including Formulations and Consumer Healthcare Products.
- Headquarter Delhi, India
- Employees 21320 as on 31 Mar, 2024
- Founders Greesh Juneja, Ramesh Chand Juneja, Ramesh Juneja, Rajeev Juneja
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mankind Pharma Ltd.
-
Annual Revenue
$1.43 B (USD)18.99as on Mar 31, 2025
-
Net Profit
$233.05 M (USD)4.08as on Mar 31, 2025
-
EBITDA
$362.97 M (USD)21.13as on Mar 31, 2025
-
Total Equity Funding
$367.2 M (USD)
in 2 rounds
-
Latest Funding Round
$350 M (USD), Private Equity Round
Apr 02, 2018
-
Investors
ChrysCapital
& 1 more
-
Employee Count
21320
as on Mar 31, 2024
-
Investments & Acquisitions
BSV Group
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Mankind Pharma
Mankind Pharma is a publicly listed company on the NSE with ticker symbol MANKIND in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Mankind Pharma
Mankind Pharma offers a comprehensive portfolio of products and services, including Formulations and Consumer Healthcare Products.
A range of pharmaceutical formulations across acute and chronic therapeutic areas is developed and marketed to address patient needs.
Products for the non-prescription segment, such as antacids and condoms, are offered to meet everyday healthcare requirements.
People of Mankind Pharma
Unlock access to complete
Funding Insights of Mankind Pharma
Mankind Pharma has successfully raised a total of $367.2M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $350 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mankind Pharma
Mankind Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include ChrysCapital and Monet.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focusing on private equity in sectors like financial services and healthcare.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Mankind Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mankind Pharma
Mankind Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BSV Group and Upakarma.
Investment portfolio details for Mankind Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Internet first D2C brand offering ayurvedic health, beauty, immunity & wellness products
|
Locked | Locked | 2017 | Locked | |
|
Provider of drug research & development services for pharmaceutical sector
|
Locked | Locked | 1971 | Locked |
Complete acquisition details for Mankind Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Mankind Pharma
Detailed financials for Mankind Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mankind Pharma Comparisons
Peer comparison for Mankind Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mankind Pharma
Detailed competitors of Mankind Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mankind Pharma
Complete news archive for Mankind Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mankind Pharma
Mankind Pharma was founded in 1991 and raised its 1st funding round 16 years after it was founded.
Mankind Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Sheetal Arora is the current CEO of Mankind Pharma.
Mankind Pharma is a funded company, having raised a total of $367.2M across 2 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Mankind Pharma is 21,320.
Annual revenue of Mankind Pharma is $1.43B as on Mar 31, 2025.
Established in 1991 and headquartered in Delhi, India, the pharmaceutical company is involved in the development, manufacturing, and marketing of formulations targeting multiple therapeutic areas. These include anti-infectives, cardiovascular, gastrointestinal, respiratory, vitamins, minerals, nutrients, anti-diabetic, neurocentral nervous system, and gynaecology segments. Both acute and chronic conditions are addressed through brands such as Nurokind, Telmikind, Moxikind, Amlokind, and Gudcef.
Mankind Pharma offers Formulations and Consumer Healthcare Products.
Yes, Mankind Pharma is publicly traded on NSE under the ticker symbol MANKIND.
Mankind Pharma has 2 investors. Key investors include ChrysCapital, and Monet.
The ticker symbol of Mankind Pharma is MANKIND on NSE.
The valuation of Mankind Pharma is $216.5M as of Apr 2007.